Marea Therapeutics
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $190M
Overview
Develops innovative therapies for cardiometabolic diseases, focusing on dyslipidemia and fatty liver disease.
MetabolicCardiovascularHepatology
Technology Platform
A biologics discovery platform focused on developing monoclonal antibodies and engineered peptides that target proteins central to lipid metabolism and cardiometabolic health.
Funding History
1Total raised:$190M
Venture$190M
Opportunities
Large addressable patient population and potential for combination therapies with existing standards of care.
Risk Factors
Clinical efficacy must significantly outperform existing therapies to gain market share in a crowded treatment landscape.
Competitive Landscape
Enters a highly competitive market with established lipid-lowering drugs but targets a specific high-risk population with a differentiated biologic.